Literature DB >> 16185632

[Analysis of Spanish scientific production in rare diseases: 1990-2000].

Cristina Escudero Gómez1, Isabel Millán Santos, Manuel Posada de la Paz.   

Abstract

BACKGROUND AND
OBJECTIVE: To analyze the Spanish scientific production in a group of rare diseases selected during the period 1990-2000. MATERIAL AND
METHOD: Analysis of the following disease groups: congenital anomalies, metabolism inborn errors and primary immunodeficiencies. Bibliometric tools were used to assess and analyze the evolution of research in this area. The MEDLINE database was utilized for references search.
RESULTS: Total references recovered for the study were 2978: 82.5% original articles and 17.3% reviews. The number of authors was 14,752 and the mean author/article was 4.9%. Seven types of institutions were coded with hospitals being the most productive with 78% of articles published. The Bradford nucleus was formed by 1,288 articles and 43.2% of the total had been published in 12 journals (2.1%).
CONCLUSIONS: Despite rare diseases research is still scarce, important efforts have been made at a national level focused on the development and strengthening of research in this field. Nevertheless, it is necessary to join efforts in this field to facilitate an appropriate research policy making that may help improve the current status.

Entities:  

Mesh:

Year:  2005        PMID: 16185632     DOI: 10.1157/13078775

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  2 in total

1.  [Concept maps as a tool for the diagnosis of rare diseases].

Authors:  Manuel Ortega Calvo; José Luis Gómez-Chaparro Moreno; Antonio González-Meneses López; Javier Guillén Enríquez; Antonio Varo Baena; Elvira Fernández de la Mota
Journal:  Aten Primaria       Date:  2011-06-08       Impact factor: 1.137

Review 2.  Impact of rare diseases in oral health.

Authors:  A Molina-García; L Castellanos-Cosano; G Machuca-Portillo; M Posada-de la Paz
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.